Daniel Clark
Stock Analyst at Leerink Partners
(2.69)
# 1,663
Out of 5,154 analysts
8
Total ratings
66.67%
Success rate
25.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Maintains: Outperform | $26 → $30 | $23.36 | +28.42% | 3 | Feb 24, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $608.41 | -1.38% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $121.43 | +27.65% | 2 | Jul 17, 2025 |
Elanco Animal Health
Feb 24, 2026
Maintains: Outperform
Price Target: $26 → $30
Current: $23.36
Upside: +28.42%
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $608.41
Upside: -1.38%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $121.43
Upside: +27.65%